The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (272 million pounds) over five years over Washington's demand for sensitive data.
This move was revealed after a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesman has since stated that the United States was demanding access to biological samples for scientific study and commercial gain while was unwilling to share the resulting advantages from future treatments.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further talks to reach a agreement suitable to both sides so the nation's vital HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a high court halted a related health funding agreement following concerns were filed about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
According to statements, 16 African countries have so far agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our population if a new pandemic arise."
National Interest and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining frameworks previously set up via the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This framework is designed to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the independence and dignity of both nations."
Medical Community Response
Medical experts stated it recognised the official position, but urged that negotiations should continue since a large portion of the nation's HIV programmes depended on external financing.
"Where specific concerns arise, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it said.
The halted deal underscores the continuing tensions between receiving crucial international aid and protecting a country's data in an increasingly data-driven world.